Implant reagents.
Ended Awarded Last action
- Contract number
- HT942524F0080
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,405
Award facts
- Contract value 100% obligated
- $24,405.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- JBSA FT SAM HOUSTON, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, received a firm fixed-price call order valued at $24,405.18 under a Blanket Purchase Agreement (BPA) with the Defense Health Agency for implant reagents. The award was issued on May 4, 2022, with an ultimate completion date of March 15, 2024, and performance is scheduled at JBSA Fort Sam Houston, Texas. This contract represents a task order call against the company's larger $4.8 million single-award BPA with the Defense Health Agency, which was established to streamline procurement of specialized biomedical research solutions for the Defense Health Agency, Army Medical Command, and military health system partners through May 2027. No set-aside designation was applied to this particular call order.
Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in manufacturing advanced physiological monitoring technologies and biomedical research equipment, including wireless implantable telemetry systems, data acquisition software, and surgical supplies. The company has established itself as a critical supplier to the Defense Health Agency and multiple federal research agencies, including the National Institutes of Health, Department of Veterans Affairs, and Environmental Protection Agency. Task orders issued under the Defense Health Agency BPA have generated over $1.5 million in cumulative procurement value, with individual call orders ranging from approximately $8,320 to $235,556, supporting diverse requirements including telemetry implants, pre-implanted research animals, software systems, and specialized research support services.
Quick answers
Who was awarded contract HT942524F0080?
HT942524F0080 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on May 4, 2022.
How much is contract HT942524F0080 worth?
The government has obligated $24,405 on HT942524F0080.
Is contract HT942524F0080 an order under another contract?
Yes. HT942524F0080 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942524F0080 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award